Naito et al. found that leukemia cell lines that overexpressed P-gp were resistant to treatment with gemtuzumab ozogamicin and that combining the ADC with P-gp inhibitors such as valspodar or biricodar reversed resistance[27]. Here, PGP is linked to leukemia.